节点文献

高原健康人与高原红细胞增多症患者血浆EPO含量分析

THE PLASMA ERYTHROPOIETIN ANALYSIS IN HIGH ALTITUDE NORMAL CONTROL AND HIGH ALTITUDE POLYCYTHEMIA

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 裴澍萱次仁布芷沙珍郑俊黄益民刘舒刘艳霞张世馥牟信兵

【Author】 Pei Shuxuan, et al. (The Second People’s Hospital of Tibet Autonomous Region)

【机构】 西藏自治区第二人民医院北京市心肺血管疾病研究所中国医学科学院基础医学研究所西藏军区总医院

【摘要】 目的:通过高原人血浆EPO测定,探索高原红细胞增多症(HAPC)的发病机理。方法:采用酶标法规定111例血浆EPO。结果:藏族健康者36例,EPO均值为6.13mlU/ml;汉族健康者36例,均值为10.69mlU/ml;藏族HAPC20例,均值为13.06mlU/ml;汉族HAOC19例均值为61.24mlU/ml。结果提示:汉族无论健康组还是HAPC病人组都高于藏族;且HAPC病人EPO含量高于健康者。结论:在高原低氧环境下,EPO增加可使RBC增多,从而引起HAPC,但这不是唯一的因素,有关调控机制正在进行深入研究。

【Abstract】 We report the estimation of plasma erythropoietin (EPO) in four groups: high altitude normal control - high altitude native (Tibetan nationality) and low - level immigrant (Han nationality) ; high altitude polycythemia patients of both nationalities.The HAPC patients have statistically significant high EPO concentration than normal control, and the Han - group has higher EPO value in both control and HAPC groups. Blood hemoglobin and hematocrit have dose-response relationship with EPO value. However the relationship value is rather low. The result indicates that in high altitude, some people have excessive erythrocytosis because of high level EPO,and eventually develop HAPC. But HAPC can not be distinguished from normal control just by the basis of EPO value.

【基金】 国家自然科学基金
  • 【文献出处】 西藏医药杂志 ,TIBETAN JOURNAL OF MEDICINE , 编辑部邮箱 ,1999年02期
  • 【分类号】R594.3
  • 【被引频次】16
  • 【下载频次】112
节点文献中: